International Clinical Trial: Clinical Study of Drug Combined with Avatar Therapy for Auditory Verbal Hallucinations in Schizophrenia

Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500115546) titled 'Clinical Study of Drug Combined with Avatar Therapy for Auditory Verbal Hallucinations in Schizophrenia' on Dec. 29, 2025.

Study Type: Interventional study

Study Design: Parallel

Primary Sponsor: The Sixth People's Hospital of Datong

Condition: Schizophrenia

Intervention: Drug-combined avatar therapy ( VRT group):Avatar therapy Drug-combined CBT (CBT group) :CognitiveBehavioralTherapy(CBT)

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2025-12-30

Target Sample Size: Drug-combined avatar therapy ( VRT group):50;Drug-combined CBT (CBT group) :50;Drug-only group (control group)...